Sponsor hub
University of Michigan Rogel Cancer Center clinical trial failures
Review 51 stopped clinical trials from University of Michigan Rogel Cancer Center, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 26
- OTHER/UNKNOWN
- 22
- SAFETY
- 2
- EFFICACY/FUTILITY
- 1
Notable sponsors
- University of Michigan Rogel Cancer Center
- 51
Related phases
- Phase II
- 26
- Phase I
- 18
- Early Phase I
- 4
- Phase III
- 1
- Phase IV
- 1
Crawlable stopped-trial records
Open ExploreShowing up to 51 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Secondary Acute Myeloid Leukemia trial by University of Michigan Rogel Cancer Center. Stop reason: EFFICACY/FUTILITY.
Interim Analysis per Protocol
Phase I Lymphoma, T-Cell, Peripheral trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Lack of accrual
Phase II Anatomic Stage I Breast Cancer AJCC v8 trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Lack of Patient Interest
Phase I Stage IV Non-small Cell Lung Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Due to financial hardships suffered by the stakeholder
Phase I Biliary Tract Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Loss of funding
Phase III Gynecologic Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Lack of Patient Population
Phase I Prostate Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Cancelled by the sponsor
Phase I Myelodysplastic Syndromes trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Lack of patient population
Phase I Indolent Lymphoma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Loss of study funding
Phase I Advanced Adult Hepatocellular Carcinoma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
loss of funding
Phase II Renal Cell Carcinoma, Metastatic trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Lack of patient population
Phase II Acute Lymphoblastic Leukemia trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
The PI plans to revise the study design in a new protocol
Phase IV CYP3A4*22 trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
funding was not secured
Phase II Non-small Cell Lung Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Pharmaceutical company discontinued the study drug.
Phase I Metastatic Pancreatic Adenocarcinoma trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
based some additional data, we have decided to hold off this trial for now and will not be proceeding with this particular trial
Phase II Chronic Myeloid Leukemia trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Glioma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Low accrual
Phase II Prostate Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
due to pandemic related constraints
Phase II Urothelial Carcinoma trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
due to changing therapeutic landscape in metastatic bladder cancer and lack of radiation/immunotherapy systemic synergy in other malignancies
Phase II Metastatic Melanoma trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Study halted prematurely due to a change in the standard of care treatment
Phase II Head and Neck Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Stopped early for funding and efficacy reasons.
Phase I Leukemia, Chronic Myeloid trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
lack of funding
Phase I Lymphoma, T-Cell, Cutaneous trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Low accrual
Phase II Prostate Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Coordinating site change
Phase II Mantle Cell Lymphoma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Enrollment and/or interactions/interventions temporarily paused due to COVID-19 and expected to resume in the future. This is not a suspension of IRB approval.
Early Phase I Glial Tumor of Brain trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Withdrawn by Principal Investigator
Phase II Glioma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
low accrual
Early Phase I Urothelial Carcinoma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Low accrual
Early Phase I Cutaneous T Cell Lymphoma trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
The company pulled durvalumab from heme malignancies
Phase I Non Small Cell Lung Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Prostate Cancer Metastatic trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Closed due to slowing enrollment and negative results of a phase III trial using cabozantinib.
Phase II Prostate Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Lack of funding.
Phase I Chronic Lymphocytic Leukemia trial by University of Michigan Rogel Cancer Center. Stop reason: SAFETY.
FDA has placed all trials involving Pacritinib on Full Clinical Hold
Phase I Hepatocellular Carcinoma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
funding issues
Phase II Follicular Lymphoma trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Bexxar isn't being produced by the manufacturer as of Feb. 2014
Phase I Non-Small-Cell Lung Carcinoma trial by University of Michigan Rogel Cancer Center. Stop reason: SAFETY.
closed due to toxicity
Phase I Ovarian Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
Genzyme will no longer supply the study drug for this trial as it does not believe the study will not fully enroll within an appropriate time frame.
Phase II Squamous Cell Carcinoma, Head And Neck trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
funding withdrawn
Early Phase I Non-Small Cell Lung Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Loco-regional Esophageal Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
The study was unable the accrue the required number of patients within a reasonable time.
Phase II Multiple Myeloma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Low accrual
Phase II Squamous Cell Carcinoma of the Head and Neck (SCCHN) trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
drug is no longer manufactured
Phase I Lymphoma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Funding was removed.
Phase I Metastatic Pancreatic Carcinoma trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Study closed early secondary to inability to obtain grant funding to conduct.
Phase II Nausea trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
site terminated due to lack of enrollment
Phase II Colorectal Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
The study was discontinued due to the death of a co-investigator and a second co-investigator leaving the institution.
Phase II Urothelial Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Low study participant enrollment.
Phase II Cancer of Larynx trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
The study was discontinued prematurely due to early stopping rules.
Phase II Urothelial Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Terminated prematurely due to low accrual.
Unknown Pancreatic Cancer trial by University of Michigan Rogel Cancer Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Chronic Myeloid Leukemia trial by University of Michigan Rogel Cancer Center. Stop reason: OPERATIONAL.
Unable to obtain sufficient funding.